½ÃÀ庸°í¼­
»óǰÄÚµå
1404743

¹Ì±¹ÀÇ ÀÇ·á ÁöºÒ±â°ü BPaaS ½ÃÀå : ¼Ö·ç¼Ç ¹üÀ§º°, ±¸¸ÅÀÚ À¯Çüº°, °¡Ä¡»ç½½ ÇÁ·Î¼¼½ºº°, ±¸¸ÅÀÚ ±Ô¸ðº°, ºÎ¹®º° µ¿Ç⠺м® º¸°í¼­(2024-2030³â)

U.S. Business Process As A Service In Healthcare Payers Market Size, Share & Trends Analysis Report By Solution Coverage (Traditional BPaaS, Best-of-breed BPaaS), By Buyer Type, By Value Chain Processes, By Buyer Size, & Segment Forecasts, 2024-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 92 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹Ì±¹ÀÇ ÀÇ·á ÁöºÒ±â°ü BPaaS ½ÃÀå ¼ºÀå ¹× µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¹Ì±¹ ÀÇ·á ÁöºÒ ±â°üÀÇ ¼­ºñ½ºÇü ºñÁî´Ï½º ÇÁ·Î¼¼½º ½ÃÀå ±Ô¸ð´Â 2024-2030³â°£ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 5.62%¸¦ ±â·ÏÇÏ¿© 2030³â±îÁö 96¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

BPaaS(Business Process as a Service) °è¾àÀº ÀÇ·á ÁöºÒÀÚÀÇ ºñÁî´Ï½º ÇÁ·Î¼¼½º ¾Æ¿ô¼Ò½Ì ¼öÀÍ¿¡ Å« ±â¿©¸¦ Çϰí ÀÖÀ¸¸ç, ÀÌ ºñÀ²Àº Äڷγª19·Î ÀÎÇÑ °¡Ä¡ ±â¹Ý ÀÇ·á·ÎÀÇ ÀüȯÀ¸·Î ÁöºÒÀÚ BPaaS ½ÃÀåÀÌ È®´ëµÊ¿¡ µû¶ó Áõ°¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. È®´ëµÊ¿¡ µû¶ó »ó½ÂÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

¹Ì±¹ °ø±ÞÀÚ ¾÷°è¿¡¼­ BPaaSÀÇ Ã¤ÅÃÀÌ ºü¸£°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù. °ø±ÞÀÚ´Â ÀÌÀüºÎÅÍ Á¸ÀçÇßÁö¸¸, Affordable Care Act·Î ÀÎÇØ ´õ¿í º¸ÆíÀûÀ̰í Áß¿äÇÑ Á¸Àç°¡ µÇ¾î BPaaSÀÇ ±âȸ¸¦ Ȱ¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¹Ì±¹ ÀÇ·á ½Ã½ºÅÛÀº ¼­ºñ½º´ç ÁöºÒ ¹æ½Ä¿¡¼­ °¡Ä¡ ±â¹Ý Áø·á ¸ðµ¨·Î ÀüȯÇϰí ÀÖÀ¸¸ç, ¼­ºñ½º Á¦°øÀÇ ¾çº¸´Ù Áø·áÀÇ Áú°ú ȯÀÚ °á°ú¿¡ ´õ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù. ÀÇ·á ºñ¿ëÀÇ Áö¼ÓÀûÀÎ Áõ°¡·Î ÀÎÇØ ÀÇ·á ½Ã½ºÅÛ¿¡ ´ëÇÑ ¾Ð·ÂÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¾÷°è¿¡¼­ °¡Ä¡ ±â¹Ý ÀÇ·á ¼­ºñ½ºÀÇ º¸±ÞÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, BPaaS´Â ÀÇ·á Á¶Á÷¿¡ °í±Þ ºÐ¼® ¹× µ¥ÀÌÅÍ °ü¸® µµ±¸¿¡ ´ëÇÑ ¾×¼¼½º¸¦ Á¦°øÇÔÀ¸·Î½á °¡Ä¡ ±â¹Ý ÀÇ·á ¼­ºñ½º¸¦ Á¦°ø °¡Ä¡ ±â¹Ý ÀǷḦ Á¦°øÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù.

»ê¾÷º° ±ÔÁ¦ Áؼö¿¡´Â ´Ù¾çÇÑ »ê¾÷º° ±ÔÁ¤ Áؼö ¿ä±¸»çÇ×ÀÌ ±ÔÁ¤µÇ¾î ÀÖ½À´Ï´Ù. ÀǷẸÇè »óÈ£¿î¿ë¼º ¹× Ã¥ÀÓ¿¡ °üÇÑ ¹ý·ü(HIPAA), °æÁ¦ ¹× ÀÓ»ó °Ç°­À» À§ÇÑ ÀÇ·á Á¤º¸ ±â¼ú(HITECH), °áÁ¦ Ä«µå »ê¾÷ µ¥ÀÌÅÍ º¸¾È Ç¥ÁØ(PCI DSS)Àº ¾÷°è¿¡ ¿µÇâÀ» ¹ÌÄ£ ¸î °¡Áö ¹ý·üÀÔ´Ï´Ù. ¸¹Àº °æ¿ì, ½ÃÀåÀº ÇöÀç ±ÔÁ¦º¸´Ù´Â °ü¸® Ȱµ¿À¸·Î ÄÄÇöóÀ̾𽺠°ü¸®¸¦ Áö¿øÇϰí ÀÖÀ¸¸ç, BPaaS Á¦°ø¾÷ü´Â ¾÷Á¾ °£ ÄÄÇöóÀ̾𽺠°ÝÂ÷¸¦ ÇØ¼ÒÇÏ°í ±âÁ¸ ±ÔÁ¦ º¯°æ¿¡ ÀûÀÀÇÒ ¼ö ÀÖ´Â BPaaS ¼Ö·ç¼ÇÀ» ±¸ÇöÇÒ ¼ö ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È ÅëÇØ äÅÃÀÌ Áõ°¡ÇÏ¿© »ê¾÷ ¼ºÀåÀ¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù.

¹Ì±¹ÀÇ BPO ½ÃÀå º¸°í¼­ : ÇÏÀ̶óÀÌÆ®

  • ¼Ö·ç¼Ç Ä¿¹ö¸®Áö¿¡ µû¶ó ½ÃÀåÀº ±âÁ¸°ú º£½ºÆ® ¿Àºê ºí·¹À̵å·Î ±¸ºÐµË´Ï´Ù. ±âÁ¸ BPaaS ºÎ¹®Àº ³·Àº ¼­ºñ½º ºñ¿ë°ú ³ôÀº °í°´ ¸¸Á·µµ·Î ÀÎÇØ 2023³â 75% ÀÌ»óÀÇ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ±¸¸ÅÀÚ À¯Çüº°·Î´Â 2023³â Á¤ºÎ ±¸¸ÅÀÚ ºÎ¹®ÀÌ 73% ÀÌ»óÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¤ºÎ º¸Çè»ç´Â ÀÇ·áºñ °ü¸® Á¤º¸ ½Ã½ºÅÛ(MMIS)ÀÇ ¸ðµâ ±¸ÇöÀ¸·Î ÀÎÇØ ¿ª»çÀûÀ¸·Î BPaaSÀÇ ÁÖ¿ä ±¸¸ÅÀÚ¿´½À´Ï´Ù.
  • Áß¼ÒÇü ÁöºÒÀÚ´Â 2023³â Àüü ÁöºÒÀÚÀÇ 70% ÀÌ»óÀ» Â÷ÁöÇÒ °ÍÀ̸ç, BPaaS ¸ðµ¨À» ´õ ¼±È£ÇÏ´Â °æÇâÀ» º¸À̰í ÀÖ½À´Ï´Ù. Ç÷£ À¯Çüº°·Î´Â ¸ÞµðÄÉ¾î ¾îµå¹êƼÁö(Medicare Advantage)¿Í ¸Å´ÏÁöµå ¸ÞµðÄÉÀ̵å(Managed Medicaid)°¡ ½ÇÇà °¡´ÉÇÑ ºñÁî´Ï½º »ç·Ê·Î ºÎ»óÇϰí ÀÖÀ¸¸ç, MA°¡ ½ÃÀå¿¡¼­ Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
  • °¡Ä¡»ç½½ÀÇ ÇÁ·Î¼¼½º¿¡¼­ ÄÉ¾î ¸Å´ÏÁö¸ÕÆ®¿Í °°Àº °ü¸® ÇÁ·Î¼¼½º°¡ BPaaS¸¦ °¡Àå ¸¹ÀÌ Ã¤ÅÃÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ÁöºÒÀÚ´Â ÀÇ·áºñ Àý°¨»Ó¸¸ ¾Æ´Ï¶ó Ŭ·¹ÀÓ °ü¸®, Áý´Ü °Ç°­ °ü¸®, ȸ¿ø Âü¿© µîÀÇ ÇÁ·Î¼¼½º¿¡¼­ BPaaSÀÇ ÀáÀç·ÂÀ» Á¡Â÷ ÀνÄÇϱ⠽ÃÀÛÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óÀ§ ½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ºñÁî´Ï½º ȯ°æ ºÐ¼® Åø
    • PorterÀÇ Five Forces ºÐ¼®
    • PESTLE ºÐ¼®
  • ¹Ì±¹ ÀÇ·á ÁöºÒ±â°ü BPaaS ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ
  • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©

Á¦4Àå ¹Ì±¹ÀÇ ÀÇ·á ÁöºÒ±â°ü BPaaS ½ÃÀå : ¼Ö·ç¼Ç Ä¿¹ö¸®Áö ÃßÁ¤¡¤µ¿Ç⠺м®

  • ¹Ì±¹ÀÇ ÀÇ·á ÁöºÒ±â°ü BPaaS ½ÃÀå ¼Ö·ç¼Ç Ä¿¹ö¸®Áö À¯Çü º¯µ¿ ºÐ¼®, 2023³â ¹× 2030³â
  • ¹Ì±¹ÀÇ ÀÇ·á ÁöºÒ±â°ü BPaaS ½ÃÀå : ¼Ö·ç¼Ç Ä¿¹ö¸®Áö ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ BPaaS
    • ±âÁ¸ BPaaS
    • ÃÖ°í bpaas

Á¦5Àå ¹Ì±¹ÀÇ ÀÇ·á ÁöºÒ±â°ü BPaaS ½ÃÀå : ±¸ÀÔÀÚ À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

  • ¹Ì±¹ÀÇ ÀÇ·á ÁöºÒ±â°ü BPaaS ½ÃÀå ±¸ÀÔÀÚ À¯Çü º¯µ¿ ºÐ¼®, 2023³â ¹× 2030³â
  • ¹Ì±¹ÀÇ ÀÇ·á ÁöºÒ±â°ü BPaaS ½ÃÀå : ±¸ÀÔÀÚ À¯Çü ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ BPaaS
    • Á¤ºÎ ±¸ÀÔÀÚ
    • »ó¾÷ ¹ÙÀ̾î

Á¦6Àå ÀÇ·á ÁöºÒ±â°ü BPaaS ½ÃÀå : ¹ë·ùüÀÎ ÇÁ·Î¼¼½º ÃßÁ¤¡¤µ¿Ç⠺м®

  • ¹Ì±¹ÀÇ ÀÇ·á ÁöºÒ±â°ü BPaaS ½ÃÀå ¹ë·ùüÀÎ ÇÁ·Î¼¼½º º¯µ¿ ºÐ¼®, 2023³â ¹× 2030³â
  • ¹Ì±¹ÀÇ ÀÇ·á ÁöºÒ±â°ü BPaaS ½ÃÀå : ¹ë·ùüÀÎ ÇÁ·Î¼¼½º ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ BPaaS
    • Ŭ·¹ÀÓ °ü¸®
    • ¸â¹ö °ü¿©
    • Äɾî¸Þ´ÏÁö¸ÕÆ®
    • ±âŸ

Á¦7Àå ¹Ì±¹ÀÇ ÀÇ·á ÁöºÒ±â°ü BPaaS ½ÃÀå : ¹ÙÀÌ¾î ±Ô¸ð ÃßÁ¤¡¤µ¿Ç⠺м®

  • ¹Ì±¹ÀÇ ÀÇ·á ÁöºÒ±â°ü ½ÃÀå ¼­ºñ½º·Î¼­ÀÇ ºñÁî´Ï½º ÇÁ·Î¼¼½º(BPaaS) ¹ÙÀÌ¾î ±Ô¸ð º¯µ¿ ºÐ¼®, 2023³â ¹× 2030³â
  • ¹Ì±¹ ÇコÄÉ¾î º¸ÇèÀÚ ½ÃÀå Business Process as a Service(BPaaS) : ¹ÙÀÌ¾î ±Ô¸ð ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ BPaaS
    • ¼Ò±Ô¸ð ¹ÙÀ̾î
    • Áß±Ô¸ð ¹ÙÀ̾î
    • ´ë±Ô¸ð ¹ÙÀ̾î

Á¦8Àå °æÀï ºÐ¼®

  • Âü¿© ±â¾÷
  • ±â¾÷ ½ÃÀå ÇöȲ ºÐ¼®
  • Àü·« ¸ÅÇÎ
    • »õ·Î¿î ¹ß¸Å
    • ÀμöÇÕº´(M&A)
    • ÆÄÆ®³Ê½Ê
    • Çù¾÷
    • ±âŸ
  • ±â¾÷ °³¿ä/¸®½ºÆ® Ç¥
    • Accenture
    • Cognizant
    • HCL Technologies Limited
    • IBM
    • Infosys Limited
    • NTT DATA Corporation
    • Optum
    • TATA Consultancy Services Limited
    • UST
    • Wipro
    • EXL
    • Softheon, Inc.
    • Genpact
    • Change Healthcare
    • Firstsource
    • Celegence
    • Highmark Health
LSH 24.01.23

U.S. Business Process As A Service in Healthcare Payers Market Growth & Trends:

The U.S. business process as a service in healthcare payers market size is expected to reach USD 9.6 billion by 2030, registering a CAGR of 5.62% from 2024 to 2030, according to a new report by Grand View Research, Inc. Business process as a service (BPaaS) engagements contributed significantly to healthcare payer business process outsourcing revenue, and this percentage is likely to rise as the market for payer BPaaS expands due to the move toward value-based care, which has been hastened by COVID-19.

The adoption of BPaaS in the U.S. providers industry is growing quickly. Although providers have been around for a while, the Affordable Care Act made them more common and significant, which makes them well-suited to take advantage of BPaaS opportunity. The U.S. healthcare system is shifting from a fee-for-service to a value-based care model, which emphasizes quality of care and patient outcomes over volume of services provided. Growing pressure on the health system as a result of a constant increase in healthcare costs is contributing to rising penetration of value-based healthcare services in industry. BPaaS can help in delivering value-based care by providing healthcare organizations access to advanced analytics and data management tools.

The industry-specific regulatory compliances specify a range of compliance requirements for various industrial verticals. Health Insurance Portability and Accountability Act (HIPAA), Health Information Technology for Economic and Clinical Health (HITECH), and Payment Card Industry Data Security Standard (PCI DSS) are a few legislations that have impacted industry. In many instances, the market now supports compliance management as an administrative activity rather than a regulatory one. BPaaS providers could implement BPaaS solutions that can bridge compliance gaps between verticals and adapt to changes in existing regulations, leading to industry's growth with a rise in adoption throughout the forecast period as all compliance adherence difficulties can be managed with their assistance.

U.S. Business Process As A Service In Healthcare Payers Market Report Highlights:

  • Based on solution coverage, the market has been segmented into traditional and best-of-breed. Traditional BPaaS segment has accounted for the largest market share of over 75% in 2023, owing to lower cost of service and higher customer satisfaction
  • Based on buyer type, the government buyers segment held the majority of revenue share of over 73% in 2023. Government insurance companies have historically been main buyers for BPaaS due to modular implementations of medicaid management information systems (MMIS)
  • Small and medium-sized payers make up more than 70% of all payers in 2023 and have shown a stronger preference for the BPaaS model. In terms of plan types, medicare advantage and managed Medicaid have emerged as viable business cases, with MA accounting for a significant share percentage of the market
  • Based on value chain processes, administrative processes such as care management have seen the most BPaaS adoption. Payers are, however, progressively becoming aware of BPaaS's potential in processes such as claims management, population health management, and member engagement as well as in reducing medical expenses

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Segment Definition
      • 1.1.1.1 Solution coverage
      • 1.1.1.2 Buyer type
      • 1.1.1.3 Value chain processes
      • 1.1.1.4 Buyer size
  • 1.2 Research Methodology
    • 1.2.1 Information procurement
      • 1.2.1.1 Purchased database
      • 1.2.1.2 GVR'S internal database
      • 1.2.1.3 Secondary sources
      • 1.2.1.4 Primary research
  • 1.3 Information or Data Analysis
    • 1.3.1 Data Analysis Models
  • 1.4 Market Formulation & Validation
  • 1.5 Model Details
  • 1.6 List of Secondary Sources
  • 1.7 List of Abbreviations
  • 1.8 Objectives
    • 1.8.1 Objective - 1
    • 1.8.2 Objective - 2
    • 1.8.3 Objective - 3

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Changing regulations
      • 3.2.1.2 Expanding healthcare consumerism
      • 3.2.1.3 Shift towards value-based healthcare
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Risk Concerns Regarding Data Security
      • 3.2.2.2 High costs
  • 3.3 Business Environment Analysis Tools
    • 3.3.1 Porter's Five Forces Analysis
    • 3.3.2 PESTLE Analysis
  • 3.4 Impact of COVID-19 on U.S. Business Process as a Service (BPaaS) in Healthcare Payer Market
  • 3.5 Regulatory Framework

Chapter 4 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Solution Coverage Estimates & Trend Analysis

  • 4.1 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market Solution Coverage Type Movement Analysis, 2023 & 2030
  • 4.2 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Solution Coverage Segment Dashboard
  • 4.3 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market Size & Forecast and Forecasts, By Solution Coverage (USD Billion)
    • 4.3.1 Traditional BPaaS
      • 4.3.1.1 Traditional BPaaS market, 2018 - 2030 (USD Billion)
      • 4.3.1.2 End-to-end traditional BPaaS
      • 4.3.1.2.1 End-to-end traditional BPaaS market, 2018 - 2030 (USD Billion)
      • 4.3.1.3 Process-specific traditional BPaaS
      • 4.3.1.3.1 Process-specific traditional BPaaS market, 2018 - 2030 (USD Billion)
    • 4.3.2 Best-of-Breed bpaas
      • 4.3.2.1 Best-of-breed bpaas market, 2018 - 2030 (USD Billion)
      • 4.3.2.2 End-to-end best-of-breed BPaaS
      • 4.3.2.2.1 End-to-end best-of-breed BPaaS market, 2018 - 2030 (USD Billion)
      • 4.3.2.3 Process-specific best-of-breed BPaaS
      • 4.3.2.3.1 Process-specific best-of-breed BPaaS market, 2018 - 2030 (USD Billion)

Chapter 5 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Buyer Type Estimates & Trend Analysis

  • 5.1 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market Buyer Type Movement Analysis, 2023 & 2030
  • 5.2 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Buyer Type Segment Dashboard
  • 5.3 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market Size & Forecast and Forecasts, By Buyer Type (USD Billion)
    • 5.3.1 Government buyers
      • 5.3.1.1 Government Buyers Market, 2018 - 2030 (USD Billion)
      • 5.3.1.2 Medicare advantage
      • 5.3.1.2.1 Medicare Advantage Market, 2018 - 2030 (USD Billion)
      • 5.3.1.3 Managed Medicaid
      • 5.3.1.3.1 Managed Medicaid market, 2018 - 2030 (USD Billion)
    • 5.3.2 Commerical buyers
      • 5.3.2.1 Commercial Buyers Market, 2018 - 2030 (USD Billion)
      • 5.3.2.2 Individual Health Plans
      • 5.3.2.2.1 Individual health plans market, 2018 - 2030 (USD Billion)
      • 5.3.2.3 Employer-sponsored health plan
      • 5.3.2.3.1 Employer sponsored health plan market, 2018 - 2030 (USD Billion)

Chapter 6 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Value Chain Processes Estimates & Trend Analysis

  • 6.1 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market Value Chain Processes Movement Analysis, 2023 & 2030
  • 6.2 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Value Chain Processes Segment Dashboard
  • 6.3 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market Size & Forecast and Forecasts, By Value Chain Processes (USD Billion)
    • 6.3.1 Claims Management
      • 6.3.1.1 Claims Management Market, 2018 - 2030 (USD Billion)
    • 6.3.2 Member engagement
      • 6.3.2.1 Member engagement market, 2018 - 2030 (USD Billion)
    • 6.3.3 Care management
      • 6.3.3.1 Care management market, 2018 - 2030 (USD Billion)
    • 6.3.4 Others
      • 6.3.4.1 Others market, 2018 - 2030 (USD Billion)

Chapter 7 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Buyer Size Estimates & Trend Analysis

  • 7.1 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market Buyer Size Movement Analysis, 2023 & 2030
  • 7.2 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market: Buyer Size Segment Dashboard
  • 7.3 U.S. Business Process as a Service (BPaaS) in Healthcare Payers Market Size & Forecast and Forecasts, By Buyer Size (USD Billion)
    • 7.3.1 Small buyers
      • 7.3.1.1 Small Buyers Market, 2018 - 2030 (USD Billion)
    • 7.3.2 Mid-sized buyers
      • 7.3.2.1 Mid-sized buyers market, 2018 - 2030 (USD Billion)
    • 7.3.3 Large buyers
      • 7.3.3.1 Large Buyers Market, 2018 - 2030 (USD Billion)

Chapter 8 Competitive Analysis

  • 8.1 Participant Categorization
  • 8.2 Company Market Position Analysis
  • 8.3 Strategy Mapping
    • 8.3.1 New Launch
    • 8.3.2 Mergers & acquisition
    • 8.3.3 Partnerships
    • 8.3.4 Collaborations
    • 8.5.5 Others
  • 8.4 Company Profiles/ Listing
    • 8.4.1 Accenture
      • 8.4.1.1 Company overview
      • 8.4.1.2 Financial performance
      • 8.4.1.3 Product benchmarking
      • 8.4.1.4 Strategic initiatives
    • 8.4.2 Cognizant
      • 8.4.2.1 Company overview
      • 8.4.2.2 Financial performance
      • 8.4.2.3 Product benchmarking
      • 8.4.2.4 Strategic initiatives
    • 8.4.3 HCL Technologies Limited
      • 8.4.3.1 Company overview
      • 8.4.3.2 Financial performance
      • 8.4.3.3 Product benchmarking
      • 8.4.3.4 Strategic initiatives
    • 8.4.4 IBM
      • 8.4.4.1 Company overview
      • 8.4.4.2 Financial performance
      • 8.4.4.3 Product benchmarking
      • 8.4.4.4 Strategic initiatives
    • 8.4.5 Infosys Limited
      • 8.4.5.1 Company overview
      • 8.4.5.2 Financial performance
      • 8.4.5.3 Product benchmarking
      • 8.4.5.4 Strategic initiatives
    • 8.4.6 NTT DATA Corporation
      • 8.4.6.1 Company overview
      • 8.4.6.2 Financial performance
      • 8.4.6.3 Product benchmarking
      • 8.4.6.4 Strategic initiatives
    • 8.4.7 Optum
      • 8.4.7.1 Company overview
      • 8.4.7.2 Financial performance
      • 8.4.7.3 Product benchmarking
      • 8.4.7.4 Strategic initiatives
    • 8.4.8 TATA Consultancy Services Limited
      • 8.4.8.1 Company overview
      • 8.4.8.2 Financial performance
      • 8.4.8.3 Product benchmarking
      • 8.4.8.4 Strategic initiatives
    • 8.4.9 UST
      • 8.4.9.1 Company overview
      • 8.4.9.2 Financial performance
      • 8.4.9.3 Product benchmarking
      • 8.4.9.4 Strategic initiatives
    • 8.4.10 Wipro
      • 8.4.10.1 Company overview
      • 8.4.10.2 Financial performance
      • 8.4.10.3 Product benchmarking
      • 8.4.10.4 Strategic initiatives
    • 8.4.11 EXL
      • 8.4.11.1 Company overview
      • 8.4.11.2 Financial performance
      • 8.4.11.3 Product benchmarking
      • 8.4.11.4 Strategic initiatives
    • 8.4.12 Softheon, Inc.
      • 8.4.12.1 Company overview
      • 8.4.12.2 Financial performance
      • 8.4.12.3 Product benchmarking
      • 8.4.12.4 Strategic initiatives
    • 8.4.13 Genpact
      • 8.4.13.1 Company overview
      • 8.4.13.2 Financial performance
      • 8.4.13.3 Product benchmarking
      • 8.4.13.4 Strategic initiatives
    • 8.4.14 Change Healthcare
      • 8.4.14.1 Company overview
      • 8.4.14.2 Financial performance
      • 8.4.14.3 Product benchmarking
      • 8.4.14.4 Strategic initiatives
    • 8.4.15 Firstsource
      • 8.4.15.1 Company overview
      • 8.4.15.2 Financial performance
      • 8.4.15.3 Product benchmarking
      • 8.4.15.4 Strategic initiatives
    • 8.4.16 Celegence
      • 8.4.16.1 Company overview
      • 8.4.16.2 Financial performance
      • 8.4.16.3 Product benchmarking
      • 8.4.16.4 Strategic initiatives
    • 8.4.17 Highmark Health
      • 8.4.17.1 Company overview
      • 8.4.17.2 Financial performance
      • 8.4.17.3 Product benchmarking
      • 8.4.17.4 Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦